aTYR PHARMA INC Property, Plant and Equipment
aTYR PHARMA INC (ATYR) had Property, Plant and Equipment of $4.13 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-07
- 2026-06-30: Property, Plant and Equipment, Net $4.13M.
- 2026-03-31: Property, Plant and Equipment, Net $4.24M.
- 2025-12-31: Property, Plant and Equipment, Net $4.26M.
- 2025-09-30: Property, Plant and Equipment, Net $4.43M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $4.13M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.24M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.26M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $4.43M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.53M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.68M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $4.85M 10-K · filed 2026-03-05 |
| 2024-09-30 | $5.02M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.18M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $5.35M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $5.53M 10-K · filed 2025-03-13 |
| 2023-09-30 | $5.64M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.81M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $5.17M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.06M 10-K · filed 2024-03-14 |
| 2022-09-30 | $1.27M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $558.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $433.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $543.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $707.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $751.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $874.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $899.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.14M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.28M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $1.27M 10-K · filed 2021-03-24 |
| 2019-09-30 | $1.39M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.51M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.69M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $1.85M 10-K · filed 2020-03-26 |
| 2018-09-30 | $2.04M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.22M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.37M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.28M 10-K · filed 2019-03-26 |
| 2017-09-30 | $2.19M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $2.00M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.62M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $1.42M 10-K · filed 2018-03-20 |
| 2016-09-30 | $1.60M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.77M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $1.84M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $1.79M 10-K · filed 2017-03-16 |
| 2015-09-30 | $1.84M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $2.02M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $1.84M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $1.93M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |